Skip to main content
Top
Published in: Inflammation 4/2008

01-08-2008

Inflammation Markers in Individuals with History of Mental Health Crisis

Authors: Dan Justo, Yaron Arbel, Gal Altberg, Michael Kinori, Arie Shirom, Samuel Melamed, Itzhak Shapira, Ori Rogowski

Published in: Inflammation | Issue 4/2008

Login to get access

Abstract

The association between temporary emotional states and systemic inflammation has never been studied. We measured the levels of systemic inflammation markers in the peripheral blood of individuals with history of mental health crisis. Erythrocyte sedimentation rate (ESR), fibrinogen plasma level, high-sensitivity C-reactive protein (hs-CRP) serum level, and white blood cell count (WBCC) were measured for each individual during routine screening examinations. History of mental health crisis was self-reported. Individuals taking psychotropic agents were excluded. A total of 4,669 males and 2,576 females were included. One hundred forty-eight (2.0%) individuals (77 males and 71 females) reported a history of mental health crisis, and 7,097 (98.0%) individuals (4,592 males and 2,505 females) did not report a history of mental health crisis. After adjustment for multiple confounders which had been associated with elevated systemic inflammation markers, the levels of systemic inflammation markers were significantly higher among males with history of mental health crisis compared with males with no history of mental health crisis, including fibrinogen plasma levels (294 ± 6.1 vs. 279 ± 1.9 mg/dl, p = 0.010), and WBCC (7.2 ± 0.2 vs. 6.8 ± 0.1 × 103 cells/dl, p = 0.039). The levels of systemic inflammation markers were not significantly higher among females with history of mental health crisis compared with females with no history of mental health crisis. History of mental health crisis might be associated with systemic inflammation in males. This finding may be relevant to the pathophysiology of cardiovascular disease in males.
Literature
1.
go back to reference Davidson, M. 2002. Risk of cardiovascular disease and sudden death in schizophrenia. J. Clin. Psychiatry. 63(Suppl 9):5–11.PubMed Davidson, M. 2002. Risk of cardiovascular disease and sudden death in schizophrenia. J. Clin. Psychiatry. 63(Suppl 9):5–11.PubMed
2.
go back to reference Krishnan, K. R. 2000. Depression as a contributing factor in cerebrovascular disease. Am. Heart J. 140(4 Suppl):70–76 (Oct).PubMedCrossRef Krishnan, K. R. 2000. Depression as a contributing factor in cerebrovascular disease. Am. Heart J. 140(4 Suppl):70–76 (Oct).PubMedCrossRef
3.
go back to reference Rutledge, T., S. E. Reis, M. B. Olson, et al. 2006. Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: The NHLBI-sponsored WISE study. Arch. Gen. Psychiatry 63(8):874–880 (Aug).PubMedCrossRef Rutledge, T., S. E. Reis, M. B. Olson, et al. 2006. Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: The NHLBI-sponsored WISE study. Arch. Gen. Psychiatry 63(8):874–880 (Aug).PubMedCrossRef
4.
go back to reference Lett, H. S., J. A. Blumenthal, M. A. Babyak, et al. 2004. Depression as a risk factor for coronary artery disease: Evidence, mechanisms, and treatment. Psychosom. Med. 66(3):305–315 (May–Jun).PubMedCrossRef Lett, H. S., J. A. Blumenthal, M. A. Babyak, et al. 2004. Depression as a risk factor for coronary artery disease: Evidence, mechanisms, and treatment. Psychosom. Med. 66(3):305–315 (May–Jun).PubMedCrossRef
5.
go back to reference Toker, S., A. Shirom, I. Shapira, et al. 2005. The association between burnout, depression, anxiety, and inflammation biomarkers: C-reactive protein and fibrinogen in men and women. J. Occup. Health Psychol. 10(4):344–362 (Oct).PubMedCrossRef Toker, S., A. Shirom, I. Shapira, et al. 2005. The association between burnout, depression, anxiety, and inflammation biomarkers: C-reactive protein and fibrinogen in men and women. J. Occup. Health Psychol. 10(4):344–362 (Oct).PubMedCrossRef
6.
go back to reference Schins, A., D. Tulner, R. Lousberg, et al. 2005. Inflammatory markers in depressed post-myocardial infarction patients. J. Psychiatr. Res. 39(2):137–144 (Mar).PubMedCrossRef Schins, A., D. Tulner, R. Lousberg, et al. 2005. Inflammatory markers in depressed post-myocardial infarction patients. J. Psychiatr. Res. 39(2):137–144 (Mar).PubMedCrossRef
7.
go back to reference Douglas, K. M., A. J. Taylor, and P. G. O’Malley. 2004. Relationship between depression and C-reactive protein in a screening population. Psychosom. Med. 66(5):679–683 (Sep–Oct).PubMedCrossRef Douglas, K. M., A. J. Taylor, and P. G. O’Malley. 2004. Relationship between depression and C-reactive protein in a screening population. Psychosom. Med. 66(5):679–683 (Sep–Oct).PubMedCrossRef
8.
go back to reference Ford, D. E., and T. P. Erlinger. 2004. Depression and C-reactive protein in US adults: Data from the Third National Health and Nutrition Examination Survey. Arch. Intern. Med. 164(9):1010–1014 (May 10).PubMedCrossRef Ford, D. E., and T. P. Erlinger. 2004. Depression and C-reactive protein in US adults: Data from the Third National Health and Nutrition Examination Survey. Arch. Intern. Med. 164(9):1010–1014 (May 10).PubMedCrossRef
9.
10.
go back to reference Ross, R. 1999. Atherosclerosis—An inflammatory disease. N. Engl. J. Med. 340(2):115–126 (January 14).PubMedCrossRef Ross, R. 1999. Atherosclerosis—An inflammatory disease. N. Engl. J. Med. 340(2):115–126 (January 14).PubMedCrossRef
12.
go back to reference Black, P. H., and L. D. Garbutt. 2002. Stress, inflammation and cardiovascular disease. J. Psychosom. Res. 52(1):1–23 (Jan).PubMedCrossRef Black, P. H., and L. D. Garbutt. 2002. Stress, inflammation and cardiovascular disease. J. Psychosom. Res. 52(1):1–23 (Jan).PubMedCrossRef
13.
go back to reference Muhlestin, J. B. 2000. Post-hospitalization management of high-risk coronary patients. Am. J. Cardiol. 85(5A):13B–20B (Mar 9).PubMedCrossRef Muhlestin, J. B. 2000. Post-hospitalization management of high-risk coronary patients. Am. J. Cardiol. 85(5A):13B–20B (Mar 9).PubMedCrossRef
14.
go back to reference Ridker, P. M., C. P. Cannon, D. Morrow, et al. 2005. C-reactive protein levels and outcomes after statin therapy. N. Engl. J. Med. 352(1):20–28 (January 6).PubMedCrossRef Ridker, P. M., C. P. Cannon, D. Morrow, et al. 2005. C-reactive protein levels and outcomes after statin therapy. N. Engl. J. Med. 352(1):20–28 (January 6).PubMedCrossRef
15.
go back to reference Ridker, P. M. 2002. Inflammatory biomarkers, statins, and the risk of stroke: Cracking a clinical conundrum. Circulation 105(22):2583–2585 (June 4).PubMedCrossRef Ridker, P. M. 2002. Inflammatory biomarkers, statins, and the risk of stroke: Cracking a clinical conundrum. Circulation 105(22):2583–2585 (June 4).PubMedCrossRef
16.
go back to reference Wirleitner, B., B. Sperner-Unterweger, and D. Fuchs. 2004. Statins to reduce risk of depression. J. Am. Coll. Cardiol. 43(6):1132, author reply 1132–1133 (Mar 17).PubMedCrossRef Wirleitner, B., B. Sperner-Unterweger, and D. Fuchs. 2004. Statins to reduce risk of depression. J. Am. Coll. Cardiol. 43(6):1132, author reply 1132–1133 (Mar 17).PubMedCrossRef
17.
go back to reference Statins dampen depression. Health News 9(11):7, Nov 2003. Statins dampen depression. Health News 9(11):7, Nov 2003.
18.
go back to reference Pearson, T. A., G. A. Mensah, R. W. Alexander, et al. 2003. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107(3):499–511 (Jan 28).PubMedCrossRef Pearson, T. A., G. A. Mensah, R. W. Alexander, et al. 2003. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107(3):499–511 (Jan 28).PubMedCrossRef
19.
go back to reference International Committee for Standardization in Hematology. 1965. Recommendation of measurement of erythrocyte sedimentation rate of human blood. Immunochemistry 2:235–254.CrossRef International Committee for Standardization in Hematology. 1965. Recommendation of measurement of erythrocyte sedimentation rate of human blood. Immunochemistry 2:235–254.CrossRef
20.
go back to reference Clauss, A. 1957. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol. 17(4):237–246.PubMedCrossRef Clauss, A. 1957. Rapid physiological coagulation method in determination of fibrinogen. Acta Haematol. 17(4):237–246.PubMedCrossRef
21.
go back to reference Rifai, N., R. P. Tracy, and P. M. Ridker. 1999. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem. 45(12):2136–2141 (December 1).PubMed Rifai, N., R. P. Tracy, and P. M. Ridker. 1999. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem. 45(12):2136–2141 (December 1).PubMed
22.
go back to reference American Diabetes Association. 2007. Diagnosis and classification of diabetes mellitus. Diabetes Care 30(Suppl 1):S42–47 (Jan).CrossRef American Diabetes Association. 2007. Diagnosis and classification of diabetes mellitus. Diabetes Care 30(Suppl 1):S42–47 (Jan).CrossRef
23.
go back to reference Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. 2001. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285(19):2486–2497 (May 16).CrossRef Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. 2001. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285(19):2486–2497 (May 16).CrossRef
24.
go back to reference Chobanian, A. V., G. L. Bakris, H. R. Black, et al. 2003. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 289(19):2560–2572 (May 21).PubMedCrossRef Chobanian, A. V., G. L. Bakris, H. R. Black, et al. 2003. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 289(19):2560–2572 (May 21).PubMedCrossRef
25.
go back to reference Rasul, F., S. A. Stansfeld, C. L. Hart, and G. Davey Smith. 2005. Psychological distress, physical illness, and risk of coronary heart disease. J. Epidemiol. Commun. Health 59(2):140–145 (Feb).CrossRef Rasul, F., S. A. Stansfeld, C. L. Hart, and G. Davey Smith. 2005. Psychological distress, physical illness, and risk of coronary heart disease. J. Epidemiol. Commun. Health 59(2):140–145 (Feb).CrossRef
26.
go back to reference Appels, A., and E. Schouten. 1991. Burnout as a risk factor for coronary heart disease. Behav. Med. 17(2):53–59 (summer).PubMed Appels, A., and E. Schouten. 1991. Burnout as a risk factor for coronary heart disease. Behav. Med. 17(2):53–59 (summer).PubMed
27.
go back to reference Watkins, C., L. Daniels, C. Jack, et al. 2001. Accuracy of a single question in screening for depression in a cohort of patients after stroke: comparative study. BMJ 323(7322):1159 (Nov 17).PubMedCrossRef Watkins, C., L. Daniels, C. Jack, et al. 2001. Accuracy of a single question in screening for depression in a cohort of patients after stroke: comparative study. BMJ 323(7322):1159 (Nov 17).PubMedCrossRef
Metadata
Title
Inflammation Markers in Individuals with History of Mental Health Crisis
Authors
Dan Justo
Yaron Arbel
Gal Altberg
Michael Kinori
Arie Shirom
Samuel Melamed
Itzhak Shapira
Ori Rogowski
Publication date
01-08-2008
Publisher
Springer US
Published in
Inflammation / Issue 4/2008
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-008-9072-4

Other articles of this Issue 4/2008

Inflammation 4/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine